Sunshine Biopharma (SBFM) Debt Ratio (2015 - 2021)

Sunshine Biopharma's Debt Ratio history runs 7 years deep, the most recent figure standing at 0.86 for Q4 2021.

• Quarterly Debt Ratio fell 4.98% year-over-year to 0.86 in Q4 2021, while the trailing twelve-month figure through Dec 2021 was 0.86 (down 4.98% YoY) and the FY2021 annual result came in at 0.86, down 4.98% from the prior year.
• Debt Ratio was 0.86 for Q4 2021 at Sunshine Biopharma, down from 1.28 in the prior quarter.
• Across five years, Debt Ratio topped out at 2.32 in Q4 2017 and bottomed at 0.19 in Q3 2019.
• A 5-year average of 0.74 and a median of 0.55 in 2020 frame the typical range for Debt Ratio.
• Annual changes were most pronounced in 2018 — Debt Ratio sank 88.3% — and 2020, when it surged 245.09%.
• Sunshine Biopharma's Debt Ratio stood at 2.32 in 2017, then sank by 88.3% to 0.27 in 2018, then slumped by 30.55% to 0.19 in 2019, then jumped by 382.31% to 0.91 in 2020, then retreated by 4.98% to 0.86 in 2021.
• Business Quant data shows SBFM's Debt Ratio at 0.86 in Q4 2021, 1.28 in Q3 2021, and 1.13 in Q2 2021.